Expertise

 

RESOURCE


Securities litigation in Canada

In the third edition of The Securities Litigation Review, Osler lawyers provide insight on a wide range of topics relating to securities litigation in Canada.
View the publication
 

IN THE NEWS


Supreme Court decision in AstraZeneca v Apotex changes Canada’s patent landscape

Bradley White talks to Canadian Lawyer about the significance of this decision and why not having the promise doctrine is “one less mechanism” available in challenging the patent under 27(3) of the Patent Act.
What are the implications?